NIPRO CORPORATION Logo

NIPRO CORPORATION

Global manufacturer of medical devices, pharmaceuticals, and pharma packaging.

8086 | T

Overview

Corporate Details

ISIN(s):
JP3673600007
LEI:
Country:
Japan
Address:
摂津市千里丘新町3番26号

Description

NIPRO CORPORATION is a global healthcare company that develops, manufactures, and distributes a wide range of medical products. Its operations are primarily divided into three core businesses: Medical Devices, Pharmaceuticals, and Pharma Packaging. In the Medical Device segment, Nipro is a market leader in renal care, offering comprehensive solutions for dialysis and related treatments, as well as high-function products such as catheters. The Pharmaceutical business focuses on the development and production of drugs, and the company is also a prominent contract manufacturer. The Pharma Packaging division provides essential glass products and packaging solutions for the pharmaceutical industry. Nipro is dedicated to meeting the needs of front-line medical treatment through its unique products and technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 02:30
発行登録書(株券、社債券等)
Japanese 29.3 KB
2025-11-14 02:30
確認書
Japanese 8.8 KB
2025-11-14 02:30
半期報告書-第73期(2025/04/01-2026/03/31)
Japanese 305.7 KB
2025-07-18 03:47
発行登録追補書類(株券、社債券等)
Japanese 125.7 KB
2025-07-03 03:01
訂正発行登録書
Japanese 9.7 KB
2025-07-03 03:00
臨時報告書
Japanese 36.5 KB
2025-06-27 02:50
訂正発行登録書
Japanese 80.2 KB
2025-06-25 07:25
内部統制報告書-第72期(2024/04/01-2025/03/31)
Japanese 24.8 KB
2025-06-25 07:24
確認書
Japanese 8.7 KB
2025-06-25 07:24
有価証券報告書-第72期(2024/04/01-2025/03/31)
Japanese 1.8 MB
2025-03-25 07:31
訂正発行登録書
Japanese 9.7 KB
2025-03-25 07:30
臨時報告書
Japanese 23.8 KB
2025-03-21 07:31
訂正発行登録書
Japanese 9.7 KB
2025-03-21 07:30
臨時報告書
Japanese 19.2 KB
2025-03-03 02:28
訂正発行登録書
Japanese 9.8 KB

Automate Your Workflow. Get a real-time feed of all NIPRO CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NIPRO CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NIPRO CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.